Abstract—Objective: To measure white matter (WM) and gray matter (GM) atrophy and lesion load in a large population of patients with multiple sclerosis (MS) using a fully automated, operator-independent, multiparametric segmentation method. Methods: The study population consisted of 597 patients with MS and 104 control subjects. The MRI parameters were abnormal WM fraction (AWM-f), global WM-f (gWM-f), and GM fraction (GM-f). Results: Significant differences between patients with MS and control subjects included higher AWM-f and reduced gWM-f and GM-f. MRI data showed significant differences between patients with relapsing–remitting and secondary progressive forms of MS. Significant correlations between MRI parameters and between MRI ...
Background To investigate in a large cohort of patients with multiple sclerosis (MS), lesion load a...
Objective: Gray matter (GM) atrophy occurs in all multiple sclerosis (MS) phenotypes. We investigate...
Purpose: To identify the measures of focal and diffuse white matter (WM) abnormalities that are rela...
Abstract\u2014Objective: To measure white matter (WM) and gray matter (GM) atrophy and lesion load i...
OBJECTIVE: To measure white matter (WM) and gray matter (GM) atrophy and lesion load in a large ...
OBJECTIVE: To measure white matter (WM) and gray matter (GM) atrophy and lesion load in a large popu...
OBJECTIVE: To determine the relation of gray matter (GM) and white matter (WM) brain volumes, and WM...
Background Brain atrophy is a well-accepted imaging biomarker of multiple sclerosis (MS) that partia...
BACKGROUND: Regional atrophy measures may offer useful information about the causes of specific clin...
Previous studies have shown a preferential loss of grey matter in fronto-temporal regions in patient...
Abstract Background Brain atrophy appears during the progression of multiple sclerosis (MS) and is a...
Background To investigate in a large cohort of patients with multiple sclerosis (MS), lesion load an...
BACKGROUND:Cerebral atrophy is common in multiple sclerosis (MS) and selectively involves gray matte...
Background: To investigate in a large cohort of patients with multiple sclerosis (MS), lesion load a...
Background To investigate in a large cohort of patients with multiple sclerosis (MS), lesion load a...
Objective: Gray matter (GM) atrophy occurs in all multiple sclerosis (MS) phenotypes. We investigate...
Purpose: To identify the measures of focal and diffuse white matter (WM) abnormalities that are rela...
Abstract\u2014Objective: To measure white matter (WM) and gray matter (GM) atrophy and lesion load i...
OBJECTIVE: To measure white matter (WM) and gray matter (GM) atrophy and lesion load in a large ...
OBJECTIVE: To measure white matter (WM) and gray matter (GM) atrophy and lesion load in a large popu...
OBJECTIVE: To determine the relation of gray matter (GM) and white matter (WM) brain volumes, and WM...
Background Brain atrophy is a well-accepted imaging biomarker of multiple sclerosis (MS) that partia...
BACKGROUND: Regional atrophy measures may offer useful information about the causes of specific clin...
Previous studies have shown a preferential loss of grey matter in fronto-temporal regions in patient...
Abstract Background Brain atrophy appears during the progression of multiple sclerosis (MS) and is a...
Background To investigate in a large cohort of patients with multiple sclerosis (MS), lesion load an...
BACKGROUND:Cerebral atrophy is common in multiple sclerosis (MS) and selectively involves gray matte...
Background: To investigate in a large cohort of patients with multiple sclerosis (MS), lesion load a...
Background To investigate in a large cohort of patients with multiple sclerosis (MS), lesion load a...
Objective: Gray matter (GM) atrophy occurs in all multiple sclerosis (MS) phenotypes. We investigate...
Purpose: To identify the measures of focal and diffuse white matter (WM) abnormalities that are rela...